M. Kathleen Behrens - 26 Jun 2023 Form 4 Insider Report for IGM Biosciences, Inc. (IGMS)

Role
Director
Signature
/s/ Misbah Tahir, by power of attorney
Issuer symbol
IGMS
Transactions as of
26 Jun 2023
Net transactions value
+$900,000
Form type
4
Filing time
28 Jun 2023, 19:34:40 UTC
Previous filing
15 Jun 2023
Next filing
05 Jul 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IGMS Common Stock Purchase $900,000 +112,500 +52% $8.00 330,700 26 Jun 2023 See footnote F1, F2
holding IGMS Common Stock 4,568 26 Jun 2023 Direct
holding IGMS Common Stock 29,807 26 Jun 2023 See footnote F3
holding IGMS Common Stock 29,806 26 Jun 2023 See footnote F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares were purchased pursuant to an underwritten public offering of the Issuer's securities.
F2 The shares are held in the name of KBW 2005 Trust for which Reporting Person is the Trustee.
F3 The shares are held in the name of Non-Exempt Trust for Patrick R. Wilsey Under the Alfred S. Wilsey, Jr. Revocable Trust for which Reporting Person is a Trustee.
F4 The shares are held in the name of Non-Exempt Trust for Shannon K. Wilsey Under the Alfred S. Wilsey, Jr. Revocable Trust for which Reporting Person is a Trustee.